| Line 561: | Line 561: | ||
*A high strength nicotine e-cigarette has the potential to help people with schizophrenia spectrum disorders to quit or reduce smoking. | *A high strength nicotine e-cigarette has the potential to help people with schizophrenia spectrum disorders to quit or reduce smoking. | ||
*[https://scholar.google.com/scholar_url?url=https://academic.oup.com/ntr/article-pdf/23/7/1113/38521536/ntab005.pdf&hl=en&sa=T&oi=ucasa&ct=ufr&ei=yBQBYYa-NZHsyQTPkaSoDg&scisig=AAGBfm3GpEvV3isL4-eiS-xFao9KegDu2Q PDF Version] | *[https://scholar.google.com/scholar_url?url=https://academic.oup.com/ntr/article-pdf/23/7/1113/38521536/ntab005.pdf&hl=en&sa=T&oi=ucasa&ct=ufr&ei=yBQBYYa-NZHsyQTPkaSoDg&scisig=AAGBfm3GpEvV3isL4-eiS-xFao9KegDu2Q PDF Version] | ||
===2021: [https://pubmed.ncbi.nlm.nih.gov/33894796/ Switching away from Cigarette Smoking with JUUL: Populations of Special Interest]=== | |||
*Substantial rates of complete switching were consistently achieved across all medico-socio-demographic subgroups 12 months following the purchase of the JSK. The potential benefits of switching with JUUL on smokers are likely to be experienced by a wide range of adult smokers. | |||
===2019: [https://pubmed.ncbi.nlm.nih.gov/31169077/ Electronic Cigarette Use During a Randomized Trial of Interventions for Smoking Cessation Among Medicaid Beneficiaries with Mental Illness]=== | ===2019: [https://pubmed.ncbi.nlm.nih.gov/31169077/ Electronic Cigarette Use During a Randomized Trial of Interventions for Smoking Cessation Among Medicaid Beneficiaries with Mental Illness]=== | ||
edits